The Identification of Proliferating Cells in Nervous System Neoplasms by Use of the Monoclonal Antibody Ki-67

0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

In an estimate of the proliferative potential of nervous system neoplasms in 100 adult patients, the proliferating cells (G1, S, G2, and M phases) were demonstrated immunohistochemically by means of the monoclonal antibody Ki-67. The percentage of cycling cells was calculated in immunostained frozen sections by the peroxidase-antiperoxidase method. The histologic grade and known biologic behavior of gliomas were reflected in the percentages of stained cells, which ranged from 0.3% in a pilocytic astrocytoma to 17.2% in a glioblastoma multiforme. All three cases in which stained cells constituted over 20% were metastatic carcinoma. The percentage of stained cells in pituitary adenomas showed a wider range (0.2-3.7%) than that of the S-phase fraction obtained by Nagashima et al (0.1 -1.5%). These results indicate that Ki-67 staining is technically suitable as a routine method of estimating the proliferating cell fraction of nervous system neoplasms, and this information may be useful in predicting their biologic behavior. © 1987, The Japan Neurosurgical Society. All rights reserved.

Cite

CITATION STYLE

APA

Shibata, T., Burger, P. C., & Kleihues, P. (1987). The Identification of Proliferating Cells in Nervous System Neoplasms by Use of the Monoclonal Antibody Ki-67. Neurologia Medico-Chirurgica, 27(12), 1147–1151. https://doi.org/10.2176/nmc.27.1147

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free